A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer
Clinical trial NCT03899636 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03899636
- Sponsor
- Angiodynamics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2025-04-01
- Enrollment
- 528
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.